Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
13.79
+0.11 (0.80%)
Aug 1, 2025, 4:00 PM - Market closed
Elanco Animal Health Employees
As of December 31, 2024, Elanco Animal Health had 9,450 total employees, including 9,000 full-time and 450 part-time employees. The number of employees decreased by 350 or -3.57% compared to the previous year.
Employees
9,450
Change (1Y)
-350
Growth (1Y)
-3.57%
Revenue / Employee
$468,466
Profits / Employee
$39,471
Market Cap
6.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9,450 | -350 | -3.57% |
Dec 31, 2023 | 9,800 | 60 | 0.62% |
Dec 31, 2022 | 9,740 | 740 | 8.22% |
Dec 31, 2021 | 9,000 | -1,200 | -11.76% |
Dec 31, 2020 | 10,200 | 4,120 | 67.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ELAN News
- 8 days ago - Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs - PRNewsWire
- 22 days ago - Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - PRNewsWire
- 23 days ago - Elanco's dog flu vaccine gets USDA nod - Reuters
- 23 days ago - Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PRNewsWire
- 4 weeks ago - Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - PRNewsWire
- 5 weeks ago - Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise - Benzinga
- 5 weeks ago - Elanco Releases 2024 Impact Report and Introduces New Framework - PRNewsWire
- 7 weeks ago - Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) - PRNewsWire